drugset

drugset / Trial / NCT03718091

M6620 (VX-970) in Selected Solid Tumors

NCT03718091 ↗

Phase 2 Completed 30 enrolled Massachusetts General Hospital EMD Serono · collab

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This research study is studying a drug called M6620 as a possible treatment for advanced solid tumor.

Timeline

Start: 2019-01-08
Primary completion: 2020-06-01
Completion: 2020-07-08

Publications

Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Berzosertib	Small molecule	—	Intravenous

Indications